Neuro Pharm (Konorev) Flashcards
Phenylephrine (Neo-Synephrine)
Gq
alpha1 agonist
direct adrenomimetic
Prazosin
Gq
alpha1 antagonist
alpha2-B antagonist
alpha2-C antagonist
Tamsulosin
alpha1-A antagonist
Gq
Clonidine (Catapres)
Gi
alpha2 agonist
direct adrenomimetic
Yohimbine
Gi
alpha2 antagonist
Oxymetazoline
Gi
alpha2-A agonist
Isoproterenol (Isuprel)
Gs
Beta-agonist
direct adrenomimetic
Propranolol
Gs
Beta antagonist
Dobutamine (Dobutrex)
Gs
Beta1 agonist
direct adrenomimetic
Albuterol (Ventolin)
Gs
Beta2 agonist
direct adrenomimetic
Mirabegron
Gs
Beta3 agonist
Betaxolol
Gs
Beta1 antagonist
Butoxamine
Gs
Beta2 antagonist
Fenoldopam (Corlopam)
Gs
D1 agonist
direct adrenomimetic
Bromocriptine
Gi
D2 agonist
Clozapine
Gi
D4 antagonist
Tissue - Vascular smooth muscle
Action - contraction
Receptor type - ?
alpha1
Tissue - Pupil dilation muscle
Action - contraction (dilation)
Receptor Type - ?
alpha1
Tissue - Pilomotor smooth muscle
Action - Erects hair
Receptor Type - ?
alpha1
Tissue - Prostate
Action - Contraction
Receptor Type - ?
alpha1
Tissue - Heart
Action - increases force of contraction
Receptor Type - ?
alpha1
Tissue - postsynaptic CNS neurons
Action - probably multiple…
Receptor Type - ?
alpha2
Tissue - platelet
Action - aggregation
Receptor Type - ?
alpha2
Tissue - adrenergic and cholinergic nerve terminals
Action - inhibits transmitter release
Receptor Type - ?
alpha2
Tissue - some vascular smooth muscle
Action - contraction
Receptor Type - ?
alpha2
Tissue - fat cells
Action - inhibits lipolysis
Receptor Type - ?
alpha2
Tissue - hear, juxtaglomerular cells
Action - increase force and rate of contraction; increases renin release
Receptor Type - ?
beta1
Tissue - respiratory, uterine, and vascular smooth muscle
Action - promotes smooth muscle relaxation
Receptor Type - ?
beta2
Tissue - skeletal muscle
Action - promotes potassium uptake
Receptor Type - ?
beta2
Tissue - human liver
Action - activates glycogenolysis
Receptor Type - ?
beta2
Tissue - bladder
Action - relaxes detrusor muscle
Receptor Type - ?
beta3
Tissue - fat cells
Action - activates lipolysis
Receptor Type - ?
beta3
Tissue - smooth muscle
Action - dilates renal blood vessels
Receptor Type - ?
D1
Tissue - nerve endings
Action - modulates transmitter release
Receptor Type - ?
D2
Gq agonist
increase IP3, DAG common to all
Gi agonist
decrease cAMP common to all
Gs agonist
increase cAMP common to all
Methoxamine (vasoxyl)
direct adrenomimetic
alpha agonist
Mixed alpha and beta agonists
Norepinephrine (Levophed)
Epinephrine (Adrenalin)
Terbutaline (Brethine)
Beta agonist
direct adrenomimetic
Dopamine (Intropin)
Dopamine agonist
direct adrenomimetic
tachyphylaxis
Acute decrease in response to drug after its administration.
Epi effects on cardiac function (Beta1)
Increase: force of contraction, heart rate, AVnode conduction velocity
Epi effects on vascular tone (Beta2 and Alpha1)
Increase systolic BP
Decrease diastolic BP and total peripheral vascular resistance
MAP unchanged
receptor type found in vascular beds of:
skin vessels and mucous membranes
mostly alpha1
receptor type found in vascular beds of:
skeletal muscle
alpha1 and beta2
receptor type found in vascular beds of:
renal, cerebral
D1 and alpha1
Epi effects on respiratory system (a1=a2; B1=B2)
B2 - relax bronchial m
A1 - decrease bronchial secretion and congestion within bronchial mucosa
Epi effects on skeletal muscle (B2)
B2 - muscle tremor
B2 - increases K+ uptake
Epi effects on blood glucose levels (B2, a2)
B2 - enhance liver glyconenolysis
A2 and B2 - inhibitis insulin release
Epi effect on free fatty acid levels in blood (B)
increases
Epi effect on renin (B1)
increase release
NE (a1=a2; B1»_space; B2)
Cardiac stimulant, but REDUCES HR
Vasoconstrictor = increase BP
Increase peripheral vascular resistance and BP
Affinity of NE toward B2
LOW = large increase in BP
Dopamine (D1=D2»_space; B1»_space; a1)
D1 = vasodilation (